Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™, phase III results at ASCO 2021 ...Middle East

SEOUL, South Korea, June 5, 2021 /PRNewswire/ -- Samsung Pharm Co., Ltd. announced today that the company presented the results of a phase III clinical trial of its pancreatic cancer immunotherapeutic drug candidate called 'RIAVAX™ (GV1001)' conducted in Korea at the 2021 American Society...

Hence then, the article about samsung pharm gemvax present pancreatic cancer immunotherapeutic drug riavax phase iii results at asco 2021 was published today ( Saturday 05/06/2021 - 03:31 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™, phase III results at ASCO 2021 )

Also on site :

• Man arrested on suspicion of fatal shooting in Huntington Beach
• Trump refuses ‘to think purely of peace’
• Danish authorities banned from using Bluetooth at work – media